Clinical AI gains an authoritative partner as digital therapy delivers measurable results, giving investors fresh reasons to watch DOCS, AMWL, WKL and DCYHY.
Healthcare technology has spent years promising to make medicine faster, smarter and less expensive. Two recent developments suggest parts…
Doximity, Inc. (NYSE: DOCS) is making a persuasive case that clinical AI can be both useful to physicians and financially disciplined enough to interest Wall Street. Its fiscal 2027 first-quarter report delivered accelerating revenue growth, resilient profitability and a sharp rise in…
The next compelling AI investment story may not sit in a data center. It may sit discreetly behind the ear.
Fortell, a privately held AI-hearing-aid company, is positioning itself at the intersection of custom silicon, machine learning, clinical care, and an enormous…
Doximity, Inc. (NYSE: DOCS) shares sold off into the close today but then staged a sharp rebound in the after‑hours session, with the stock surging more than 60 percent off its regular‑session levels as investors reassessed the company’s fiscal 2027 first‑quarter results…
Doximity, Inc. (NYSE: DOCS) reports fiscal first-quarter 2027 results after the market close on August 6, and the stock enters the print with the kind of setup that can either confirm a breakout story or remind investors that healthcare software, like a…
